Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2012 March;54(1) > Panminerva Medica 2012 March;54(1):29-37

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

PANMINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,6


eTOC

 

  UPDATE IN INTERNAL MEDICINE 2012


Panminerva Medica 2012 March;54(1):29-37

language: English

A 2012 clinical update for internists in adult nonalcoholic fatty liver disease

Younossi Z. M. 1, 2, 3, Venkatesan C. 1

1 Department of Internal Medicine, Inova Fairfax Hospital, Falls Church, VA, USA;
2 Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA;
3 Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA, USA


PDF  


Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the Western world. Associated with the metabolic syndrome, NAFLD is associated with adverse cardiovascular outcomes. A subset of NAFLD patients with histologic nonalcoholic steatohepatitis (NASH) can have increased liver related mortality. Because of the prevalence and complications of this chronic liver disease, it is important that internists understand important aspects about diagnosis and management. In this article, we aim to provide an update to clinicians related to issues surrounding prognosis, monitoring, and treatment.

top of page

Publication History

Cite this article as

Corresponding author e-mail

Zobair.younossi@inova.org